Stocks
Heron Therapeutics (HRTX) EV/EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -4.19 | -0.41 | -0.96 | -69.6 | -17.4 | -12.7 | ||
| Changes by years, y/y, % | -46% | -90% | +133% | +7 177% | -75% | +17.4% | |||
Heron Therapeutics. EV/EBITDA
Heron Therapeutics. EV/EBITDA, changes, %
Heron Therapeutics (HRTX) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EV/EBITDA | ? | 168.3 | 60.4 | -116.7 | -25.7 | -12.1 | -12.7 | |
| Changes by years, y/y, % | -11 915% | -2 252% | +449% | -63% | -107% | |||
| Changes by quarters, q/q, % | -341% | -64% | -293% | -78% | -53% | |||
